Evaluation of TAK-058 and Ondansetron on P50 Auditory Gating in Participants With Stable Schizophrenia

NCT02614586 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

11

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: TAK-058
DRUG: Ondansetron
DRUG: TAK-058 Placebo
DRUG: Ondansetron Placebo

Sponsor

Takeda